trending Market Intelligence /marketintelligence/en/news-insights/trending/8R8bSxjsDjC3rjj9F66K4g2 content esgSubNav
In This List

Rigel Pharmaceuticals prices common stock offering

Video

S&P Capital IQ Pro | Unrivaled Sector Coverage

Video

S&P Capital IQ Pro | Powering Your Edge

Blog

Enterprises are missing out on 24B by not optimizing cloud spending not going multicloud

Blog

Investment Research Analysts Providing Greater Coverage on Inflation


Rigel Pharmaceuticals prices common stock offering

Rigel Pharmaceuticals Inc. priced an underwritten public offering of 18,100,000 common shares at $3.35 apiece to raise about $60.6 million in gross proceeds.

The company granted underwriters a 30-day option to buy up to an additional 2,715,000 common shares at the offering price.

The offering is expected to close Oct. 10, subject to customary closing conditions.

Jefferies LLC and BMO Capital Markets Corp. are acting as joint book-running managers for the offering, with H.C. Wainwright & Co. LLC as lead manager.